Merck & Company, Inc. (MRK) Financials

MRK Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 106.7 billion 69.0 billion
2023-12-31 106.7 billion 69.0 billion
2023-09-30 106.7 billion 65.4 billion
2023-06-30 104.5 billion 65.7 billion

MRK Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -743.0 million 167.0 million
2023-12-31 -743.0 million 167.0 million
2023-09-30 6.8 billion 164.0 million
2023-06-30 2.7 billion 169.0 million

MRK Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 -1.2 billion
2023-12-31 -1.2 billion
2023-09-30 4.8 billion
2023-06-30 -6.0 billion

MRK Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 7.2 billion - -
2023-12-31 7.2 billion - -
2023-09-30 8.8 billion 34.0 billion -
2023-06-30 6.4 billion 34.1 billion -

MRK Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 2.5 billion
2023-12-31 2.5 billion
2023-09-30 2.5 billion
2023-06-30 2.5 billion

MRK Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 989.0 million 8.8 billion 451.0 million 2.3 billion
2023-12-31 989.0 million 8.8 billion 2.8 billion -
2023-09-30 902.0 million 3.3 billion 2.5 billion -
2023-06-30 965.0 million 13.3 billion 2.6 billion -

MRK Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 14.6 billion 3.3 billion
2023-12-31 14.6 billion 3.3 billion
2023-09-30 16.0 billion 4.3 billion
2023-06-30 15.0 billion 4.0 billion

MRK

List: Contenders

Price: $130.38

52 week price:
99.14
133.10

Dividend Yield: 0.02%

5-year range yield:
0.02%
3.74%

Forward Dividend Yield: 2.41%

Payout Ratio: 2200.00%

Payout Ratio Range:
26.90%
2200.00%

Dividend Per Share: 3.08 USD

Earnings Per Share: 0.91 USD

P/E Ratio: 70.23

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 7.8 million

Ebitda: 2.3 billion

Market Capitalization: 323.0 billion

Average Dividend Frequency: 4

Years Paying Dividends: 63

DGR3: 8.71%

DGR5: 9.43%

DGR10: 5.84%

DGR20: 10.47%

Links: